NasdaqGS:ATECMedical Equipment
A Look At Alphatec Holdings (ATEC) Valuation After 2026 Guidance Update And Theradaptive OsteoAdapt Deal
Alphatec Holdings (ATEC) grabbed attention after its 2026 revenue outlook implied slower growth at the same time the company secured exclusive U.S. rights to Theradaptive’s OsteoAdapt bone graft, sending the stock sharply lower.
See our latest analysis for Alphatec Holdings.
The guidance update and Theradaptive partnership arrived after a volatile stretch for the shares, with a 24.5% 7 day share price return decline and 17.6% 30 day share price return decline, even as the 1 year total...